Clinical Trial Update: Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes [NA]

View source ↗

Summary

This update outlines the planned evaluation of Medtronic's NMX8 automated insulin delivery system for adults with Type 1 diabetes, focusing on safety and effect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Medtronic NMX8 Automated Insulin Delivery System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes (T1D) | NA | Status: NOT_YET_RECRUITING